tiprankstipranks
Statera BioPharma (STAB)
OTHER OTC:STAB
US Market
Holding STAB?
Track your performance easily

Statera BioPharma (STAB) Financial Statements

190 Followers

Statera BioPharma Financial Overview

Statera BioPharma's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Statera BioPharma is scheduled to report earnings on August 14, 2023, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 22Jun 22Mar 22Dec 21Sep 21
Income Statement-
Total Revenue$ 670.50K$ 768.80K$ 997.80K$ 1.25M$ 236.52K
Gross Profit$ -169.35K-$ -353.67K$ 878.13K$ 120.59K
EBIT$ -3.36M-$ -7.76M$ -87.93M$ -12.73M
EBITDA$ -3.17M$ 131.09K$ -7.64M$ -87.93M$ -12.59M
Net Income Common Stockholders$ -3.35M$ -3.49M$ -7.76M$ -87.93M$ -12.72M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 506.10K$ 716.86K$ 330.57K$ 1.98M$ 9.45M
Total Assets$ 12.75M$ 13.54M$ 13.51M$ 21.17M$ 98.04M
Total Debt$ 7.41M$ 7.55M$ 7.12M$ 16.26M$ 16.74M
Net Debt$ 6.90M$ 6.84M$ 6.79M$ 14.28M$ 7.29M
Total Liabilities$ 22.92M$ 20.46M$ 15.94M$ 22.68M$ 23.84M
Stockholders Equity$ -10.24M$ -6.99M$ -2.49M$ -1.57M$ 74.12M
Cash Flow-
Free Cash Flow$ -801.52K$ -168.51K$ -3.77M$ -8.23M$ -15.28M
Operating Cash Flow$ -801.52K$ -168.51K$ -3.76M$ -8.13M$ -15.22M
Investing Cash Flow--$ -6.45K$ -96.91K$ 13.04M
Financing Cash Flow$ 711.65K$ 500.13K$ -2.90M$ 858.95K$ 671.79K
Currency in USD

Statera BioPharma Earnings and Revenue History

Statera BioPharma Debt to Assets

Statera BioPharma Cash Flow

Statera BioPharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis